SP-WCPV-046

SARS-CoV-2 Antigen Peptide NCAP (PNFKDQVILLNKHIDAYK)

US$269.00

In stock

Description

About SARS-CoV-2 Antigen Peptide NCAP (PNFKDQVILLNKHIDAYK)

SARS-CoV-2 Antigen Peptide NCAP (PNFKDQVILLNKHIDAYK) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide NCAP (PNFKDQVILLNKHIDAYK) - Specifications

Amount: 50 µg
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Delivery Format: Freeze-dried in plastic vial
Application(s): T-cell immunity
Condition(s)/Topic(s): Covid-19, Infection, Respiratory infection
Standard Delivery Time: 2-5 days

Visit our webpage for more information on SARS-CoV-2, its mutations & variants and our corresponding products.

Are you interested in your other antigen peptides? Choose your sequence, amount and purity. We will assist you along the way. Custom Peptide Synthesis.

JPT’s SARS-CoV-2 Antigen Peptides
Individual antigen peptides are derived from information on the human immune response towards SARS-virus, which is very similar to SARS-CoV-2. Sequences which are identical (28 peptides) or similar (13 peptides with one mutation, 7 with two and one with three) to experimentally confirmed SARS-epitopes are made available through our shop. These peptides can be used for antigen specific T-cell stimulation, T-cell assays or T-cell expansion. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Antigen Peptides
- Whole production performed in a regulated European environment according to DIN EN ISO 9001:2015 & GCLP standards; audits welcome!
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool and MHC Dextramer with your peptide as a set!

References

References for SARS-CoV-2 Antigen Peptide NCAP (PNFKDQVILLNKHIDAYK)

References:
Read References with Antigen Peptides

Documentation

Documentation for SARS-CoV-2 Antigen Peptide NCAP (PNFKDQVILLNKHIDAYK)

Properties

Properties of SARS-CoV-2 Antigen Peptide NCAP (PNFKDQVILLNKHIDAYK)

Properties Values
Amount: 50 µg
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Covid-19, Infection, Respiratory infection
Layout: Freeze-dried in plastic vial
Organism: SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2)
Protein Name: Nucleoprotein
Purity: >90% (HPLC-MS), Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: Yes

Further Information to SARS-CoV-2 Antigen Peptide NCAP (PNFKDQVILLNKHIDAYK)

Information Values
Sequence: H-PNFKDQVILLNKHIDAYK-OH
Specifications: Peptide as TFA salt
Loading...
TÜV Rheinland certified
Health - made in Germany
Quality Assurance

All production is ISO 9001:2015 certified.

Check our list of products, click and go.

Get a quote